Coronavirus News and Research

RSS

Better clinical outcomes in COVID-19 and vaccine-related myocarditis than classic myocarditis in children

Researchers have investigated the differences between 'classic' myocarditis, COVID-19 induced myocarditis, and vaccine-related myocarditis.

11 Oct 2021

West Midlands' thriving digital industries expected to create thousands of new jobs by 2025

The West Midlands has been named the country's fastest-growing tech sector and the region's thriving digital industries are expected to create thousands of new jobs by the end of 2025.

11 Oct 2021

Sero-epidemiological insights into pathways to COVID-19 immunity

A new study posted to the medRxiv* server attempts to utilize serology as a tool to identify disparities in infection rates and vaccination coverage.

10 Oct 2021

Research finds different antibody responses following COVID vaccination and natural infection

A new study published in the journal Nature attempted to investigate memory B cell evolution 5 months after vaccination with mRNA vaccines such as Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) in SARS-CoV-2 naïve individuals. The study explored various aspects of memory B cell antibody response like neutralizing response, affinity, epitope targeting, and neutralizing breadth.

10 Oct 2021

Myocarditis after mRNA COVID vaccine extremely rare, most cases mild or moderate

The estimated incidence of myocarditis among patients that have received at least one dose of the Pfizer-BioNTech (BNT162b2) mRNA vaccine against coronavirus disease 2019 (COVID-19) was 2.13 cases per 100,000 persons, primarily affecting young men and presenting mostly as mild or moderate illness, as demonstrated by a recent study published in the New England Journal of Medicine.

10 Oct 2021

The neurological effects of COVID-19

What is the relationship between COVID-19 and the brain? A new review published in Tropical Biomedicine summarizes the key findings on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe COVID-19 infection, disrupts brain activity and produces a range of long-term neurological disorders.

10 Oct 2021

Accumulation of SARS-CoV-2 mutations reduces sensitivity to neutralizing antibodies

In a new study, researchers discovered that SARS-CoV-2 mutations accumulate, especially in immunocompromised patients.

10 Oct 2021

COVID-19 vaccination rates among minority populations

A new study discusses offers insights into how minority groups can be effectively persuaded to take the currently available COVID-19 vaccines.

10 Oct 2021

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

A new study introduces the possibility that the inactivated polio vaccine can elicit antibodies that inhibit SARS-CoV-2 nucleic acid synthesis.

10 Oct 2021

Prenatal maternal distress during COVID linked to alterations in infant brain development

A new study discusses the effects of stress during pregnancy in the pandemic on the developing brain of the infant.

10 Oct 2021

Phase I clinical trial of two Cuban recombinant protein COVID-19 vaccines

The results of Phase I clinical trials for two new COVID-19 vaccine candidates based on recombinant RDB proteins are reported.

10 Oct 2021

What impact does temperature have on SARS-CoV-2 M protein dynamics?

In a recent study, the structural dynamics of the SARS-CoV-2 M protein are studied at temperatures of 10-50 ˚C using molecular dynamics simulations.

10 Oct 2021

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

The researchers assessed the effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infection and COVID-19-related hospitalization and deaths.

10 Oct 2021

Dynamic causal modeling for future projection of the COVID-19 pandemic

A new study utilizes dynamic causal modeling to predict the effects of letting SARS-CoV-2 sweep through a largely vaccinated population.

10 Oct 2021

Lipids, COVID-19, and host immunity

A new study from a team of researchers at the University of Pennsylvania examines the role played by lipids in this disease.

10 Oct 2021

Powerful neutralizing antibody against SARS-CoV-2 variants of concern

A new paper discusses a new antibody with potent neutralizing activity against the ancestral SARS-CoV-2 strain, as well as newer variants of SARS-CoV-2.

10 Oct 2021

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

Hospital admissions and deaths due to COVID-19 were drastically reduced at two weeks or more from the first dose of either the Pfizer or AstraZeneca vaccine.

10 Oct 2021

Role of S-acylation in SARS-CoV-2 infectivity

A new study published in Developmental Cell investigates S-acylation of the SARS-CoV-2 S protein.

10 Oct 2021

Severe influenza outbreak expected in the United States after relaxation of COVID control measures

New research warns that the United States could experience a severe influenza outbreak after public health measures like face masks and social distancing are lifted.

8 Oct 2021

Characterization of circulating neutrophils from hospitalized COVID-19 patients

A new preprint deals with the characterization of neutrophil phenotypes in an attempt to provide biomarkers that can predict severe disease in patients hospitalized with COVID-19.

8 Oct 2021

Coronavirus News and Research

Better clinical outcomes in COVID-19 and vaccine-related myocarditis than classic myocarditis in children

West Midlands' thriving digital industries expected to create thousands of new jobs by 2025

Sero-epidemiological insights into pathways to COVID-19 immunity

Research finds different antibody responses following COVID vaccination and natural infection

Myocarditis after mRNA COVID vaccine extremely rare, most cases mild or moderate

The neurological effects of COVID-19

Accumulation of SARS-CoV-2 mutations reduces sensitivity to neutralizing antibodies

COVID-19 vaccination rates among minority populations

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

Prenatal maternal distress during COVID linked to alterations in infant brain development

Phase I clinical trial of two Cuban recombinant protein COVID-19 vaccines

What impact does temperature have on SARS-CoV-2 M protein dynamics?

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

Dynamic causal modeling for future projection of the COVID-19 pandemic

Lipids, COVID-19, and host immunity

Powerful neutralizing antibody against SARS-CoV-2 variants of concern

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

Role of S-acylation in SARS-CoV-2 infectivity

Severe influenza outbreak expected in the United States after relaxation of COVID control measures

Characterization of circulating neutrophils from hospitalized COVID-19 patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News